The nhlbi requires the gene therapy resource program (gtrp) support translational gene therapy research by providing resources and services from three core laboratories: 1.) pharmacology and…
Ended Awarded Last action
- Contract number
- 75N92019F00074
- Awardee
-
The Trustees Of The University Of Pennsylvania UEI GM1XX56LEP58
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,677,615
Award facts
- Opportunity
-
- Gene Therapy Resource Program (GTRP) Pre-Solicitation · HHSN26818HV00005R · Posted Sep 19, 2017
- Gene Therapy Resource Program (GTRP) Award Notice · Posted Dec 21, 2018
- Contract value 100% obligated
- $1,677,614.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$146,169 | |
| Other Administrative Action | -$75,539 | |
| Exercise an Option | $389,324 | |
| Exercise an Option | $384,457 | |
| Exercise an Option | $379,728 | |
| Exercise an Option | $375,135 | |
| Original award | $370,678 |
About this award
This is a federal contract award from the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The contract, valued at $1,677,614.67, is for the Gene Therapy Resource Program (GTRP), which supports translational gene therapy research by providing resources and services from three core laboratories: the Pharmacology and Toxicology Core Laboratory, the Preclinical Vector Core Laboratory, and the Clinical Coordinating Center. The contract is a delivery order with a cost-no-fee pricing type and an ultimate completion date of December 18, 2023. The award was made on December 19, 2018, and there is no set-aside designation mentioned. The University of Pennsylvania is a prestigious private research university and academic medical center that has demonstrated significant capabilities in providing specialized services across multiple federal agencies and research domains.
Description
The nhlbi requires the gene therapy resource program (gtrp) support translational gene therapy research by providing resources and services from three core laboratories: 1.) pharmacology and toxicology core laboratory, 2.) preclinical vector core laboratory, 3.) clinical coordinating center (CCC), which is not required to have any laboratory capabilities
Quick answers
Who was awarded contract 75N92019F00074?
75N92019F00074 was awarded to The Trustees Of The University Of Pennsylvania by National Heart Lung and Blood Institute (National Institutes of Health) on December 19, 2018.
How much is contract 75N92019F00074 worth?
The government has obligated $1,677,615 on 75N92019F00074.
Is contract 75N92019F00074 an order under another contract?
Yes. 75N92019F00074 is a delivery order under 75N92019D00016, an indefinite delivery contract.
Was contract 75N92019F00074 competed?
The extent of competition for 75N92019F00074 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award